Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Aquestive Therapeutics Inc AQST

Healthcare
Aquestive Therapeutics, Inc. is a pharmaceutical company. The Company is developing pharmaceutical products to deliver complex molecules through administrations that are alternatives to invasive and inconvenient standard of care therapies. It is advancing a product pipeline for the treatment of severe allergic reactions, including anaphylaxis. It has also developed a product pipeline focused on... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:AQST)

Aquestive Therapeutics Receives U.S. FDA Approval and Market Access for Libervant(TM) (diazepam) Buccal Film in Pediatric Patients Ages 2 to 5 and Provides Update on Anaphylm(TM) (epinephrine) Sublingual Film

GlobeNewswire 5 days ago

Aquestive Therapeutics to Report First Quarter 2024 Financial Results and Recent Business Highlights on May 7 and Host Conference Call on May 8 at 8:00 a.m. ET

GlobeNewswire 9 days ago

Aquestive Therapeutics to Present Crossover Study Data for Libervant(TM) (diazepam) Buccal Film at 76th Annual Meeting of the American Academy of Neurology

GlobeNewswire April 12, 2024

Aquestive Therapeutics Strengthens Board of Directors with Experienced Biotech Executive

GlobeNewswire April 1, 2024

Aquestive Therapeutics Announces Closing of Underwritten Public Offering of Common Stock

GlobeNewswire March 25, 2024

Aquestive Therapeutics Announces Pricing of $75 Million Underwritten Public Offering of Common Stock

GlobeNewswire March 19, 2024

Aquestive Therapeutics Announces Proposed Public Offering of Common Stock

GlobeNewswire March 19, 2024

Aquestive Therapeutics Announces Pivotal Study for Anaphylm(TM) (epinephrine) Sublingual Film Successfully Meets Primary and Secondary Endpoints and Provides Clinical Development Update Following FDA Meeting

GlobeNewswire March 14, 2024

Aquestive Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update

GlobeNewswire March 5, 2024
View More News ››

Opinion & Analysis (NDAQ:AQST)

Aquestive Therapeutics Shares Up on Pipeline Update and Raised Full-Year 2019 Guidance

Streetwise Reports November 7, 2019

'Undervalued' Biopharma Features Robust Pipeline, Future Upside

Streetwise Reports April 29, 2019
View More Opinion ››

Bullboard Posts (NDAQ:AQST)

Excellent YT analysis on AQST!

https://youtu.be/0nGmma8apnE
BryceCanada - May 13, 2023

AQST - Price Drop

<< View Post To Watch Video >>
HDavis - December 21, 2021

AQST - Monday Rundown, Tuesday Expectations

<< View Post To Watch Video >>
HDavis - December 20, 2021

AQST - FDA Approval Insight

<< View Post To Watch Video >>
HDavis - December 19, 2021

AQST - FDA Approval Insight

<< View Post To Watch Video >>
HDavis - December 19, 2021

AQST - Tuesday Rundown, Wednesday Expectations

<< View Post To Watch Video >>
HDavis - November 30, 2021
View more Bullboard ››

Torr Metals Inc.

Torr Metals Inc.

Torr Metals Inc. is a Canada-based mineral exploration company. The Company is focused on defining and developing the ...
View More »